|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
on1310845707 |
| 003 |
OCoLC |
| 005 |
20240808213014.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
220414s2022 sz a ob 000 0 eng d |
| 040 |
|
|
|a GW5XE
|b eng
|e rda
|e pn
|c GW5XE
|d OCLCO
|d EBLCP
|d OCLCF
|d OCLCQ
|d CASUM
|d YDX
|d INT
|d OCLCO
|d OCLCL
|d OCLCQ
|d TEFOD
|d N$T
|d UEJ
|d OCLCO
|
| 019 |
|
|
|a 1313608105
|a 1313902509
|a 1374609190
|
| 020 |
|
|
|a 9783030945770
|q (electronic bk.)
|
| 020 |
|
|
|a 3030945774
|q (electronic bk.)
|
| 020 |
|
|
|a 9788303094575
|q (0)
|
| 020 |
|
|
|a 8303094572
|
| 020 |
|
|
|z 9783030945763
|
| 020 |
|
|
|z 3030945766
|
| 024 |
7 |
|
|a 10.1007/978-3-030-94577-0
|2 doi
|
| 035 |
|
|
|a (OCoLC)1310845707
|z (OCoLC)1313608105
|z (OCoLC)1313902509
|z (OCoLC)1374609190
|
| 037 |
|
|
|a 32E441E7-210A-4190-A78C-BA062E0046C4
|b OverDrive, Inc.
|n http://www.overdrive.com
|
| 050 |
|
4 |
|a RC270
|b .M37 2022
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 072 |
|
7 |
|a MJCL
|2 thema
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Marcus, Pamela M.,
|e author.
|1 https://id.oclc.org/worldcat/entity/E39PCjvX9W9rdhkQrX4tyvR8vd
|
| 245 |
1 |
0 |
|a Assessment of cancer screening :
|b a primer /
|c Pamela M. Marcus.
|
| 264 |
|
1 |
|a Cham :
|b Springer,
|c [2022]
|
| 264 |
|
4 |
|c ©2022
|
| 300 |
|
|
|a 1 online resource (xx, 123 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|2 rdaft
|0 http://rdaregistry.info/termList/fileType/1002
|
| 506 |
0 |
|
|a Open access
|5 GW5XE
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 520 |
|
|
|a Cancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years.
|
| 505 |
0 |
|
|a Foundations -- Behind the scenes -- Performance measures -- Population measures: definitions -- Population measures: cancer screening's impact -- Experimental research designs -- Observational research designs -- Cancer prevention screening -- Additional considerations -- Closing thoughts.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed April 14, 2022).
|
| 506 |
0 |
|
|a Open Access
|5 EbpS
|
| 650 |
|
0 |
|a Cancer
|x Diagnosis.
|
| 650 |
|
0 |
|a Medical screening.
|
| 650 |
|
7 |
|a Cancer
|x Diagnosis
|2 fast
|
| 650 |
|
7 |
|a Medical screening
|2 fast
|
| 758 |
|
|
|i has work:
|a ASSESSMENT OF CANCER SCREENING (Text)
|1 https://id.oclc.org/worldcat/entity/E39PD3383RFpyKPBgC7p37F9Xd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|z 9783030945763
|
| 776 |
0 |
8 |
|i Print version:
|z 9783030945787
|
| 856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-3-030-94577-0
|y Click for online access
|
| 903 |
|
|
|a SPRING-MED2022
|
| 994 |
|
|
|a 92
|b HCD
|